期刊文献+

高渗制备法对吗啡红细胞载体生成数及其血红蛋白含量的影响 被引量:3

Effect of Hyperosmotic Method on the Number of Carriers Erythrocyte Encapsulated Morphine and the Content of Hemoglobin
下载PDF
导出
摘要 目的 :了解高渗法制备过程中渗透压变化对吗啡红细胞载体生成数及其血红蛋白 (Hb)含量的影响。方法 :采用冰点渗透压仪测定高渗法制备吗啡红细胞载体过程中的渗透压变化 ,利用自动化血细胞分析仪、氰化高铁法、显微镜等仪器及技术 ,对制备过程中Hb释出量、红细胞计数及其显微图像等进行研究。结果 :高渗法制备过程中环境的最低渗透压为 382 1± 2 2 7mOsmol/L ;载体形成前后红细胞计数的变化无统计学意义 (P >0 0 5 ) ;红细胞经高渗法制备成吗啡载体后 ,Hb释出百分率为 (38 6± 2 8) % ;显微图像上高渗液处理的红细胞中有大量圆形空泡。结论 :高渗法制备中渗透压对吗啡红细胞载体的生成数无影响 ,但可导致红细胞中血红蛋白的大量释出 ,此现象可能与高渗糖处理后红细胞膜通透性发生了改变有关。 AIM:To illustrate the effect of hyperosmotic method on the number of carriers erythrocyte encapsulated morphine and content of hemoglobin by the change of osmotic pressure in process. METHOD:Using freezing osmotic meter to determine the change of osmotic pressure in process of hyperosmotic method to encapsulate morphine. Automated hemocyte analysis meter, microscope and iron cyanide method are used to measure the content of hemoglobin releasing, RBC count and morphologic change before and after the carrier erythrocyte was formed . RESULT:The lowest of osmotic pressure is 382.1±22.7 mOsmol/L in process of hyperosmotic method to encapsulate morphine. RBC count wasn't changed and the content of hemoglobin in releasing was about (38.6±2.8)% after forming carriers erythrocyte encapsulated morphine. There were a large number of spherical vacuoles cells formed. CONCLUSION:The number of carriers erythrocyte encapsulated morphine wasn't affected but it resulted in hemoglobin resealing in process of hyperosmotic method encapsulated morphine. The phenomenon may be related to the change of erythrocyte membrane permeability by dealing with hyperosmotic glucose.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2003年第5期410-413,共4页 Journal of China Pharmaceutical University
基金 江苏省科委社会发展基金资助项目 (编号BS2 0 0 0 0 5 6)
关键词 高渗法 吗啡 红细胞载体 血红蛋白含量 Hyperosmotic method Morphine Carriers erythrocytes Hemoglobin content
  • 相关文献

参考文献5

二级参考文献2

共引文献21

同被引文献31

  • 1王林杰,张永富.用红细胞作为药物或酶载体的研究[J].国外医学(生物医学工程分册),1995,18(2):81-86. 被引量:2
  • 2宋祥福,吕喆,刘欣,杨海山.两种方式接种肝癌模型的比较[J].中国比较医学杂志,2007,17(2):96-98. 被引量:14
  • 3霍晶,葛卫红,方芸,袁盛华.红细胞包载抗肿瘤药物研究进展[J].中国药房,2007,18(10):784-786. 被引量:2
  • 4Rask C,Albertioni F,Bentzen SM,et al.Clinical and pharmacokinetic risk factors for high dose methotrexate induced toxicity in children with acute lymphoblastic leukemia--a logistic regression analysis[J].Acta Oncol,1998,37(3):277-84.
  • 5Boffa MJ.Methotrexate for psoriasis:current European practice.A postal survey[J].J Eur Acad Dermatol Venereol,2005,19(2):196-202.
  • 6Deloach JR,Widnell CIhler GM.Phagocytosis of enzyme-containing carrier erythrocytes by macrophages[J].J App Biochem,1979,1(1-2):95-103.
  • 7Kruse CA.Ultrastructural observations on the transformations of osmotically stressed and electrically pulsed red cell carriers at stages during their formation[J].Blood Cells,1991,17(1):177.
  • 8Yuan SH,Ge WH,Huo J,Wang XH.Slow release properties and liver targeting characteristics of methotrexate erythrocyte carriers[J].Fundam Clin Pharmacol,2009,23(2):189-96.
  • 9Tian HH,Cronstein BN.Understanding the mechanisms of action of methotrexate implications for the treatment of rheumatoid arthritis[J].Bull NYU Hosp Jt Dis,2007,65(3):168-73.
  • 10Hasko G,Cronstein BN.Adenosine:an endogenous regulator of innate immunity[J].Trends Immunol,2004,25(1):33-9.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部